
|Articles|May 8, 2023
Pharma 2023: New Rules for Clinical Lay Summaries in EU
Estelle Jobson, EUPATI alumna, patient expert and health communications professional discusses changes to the EU's requirements for clinical trial lay summaries.
Advertisement
Estelle Jobson, EUPATI alumna, patient expert and health communications professional discusses changes to the EU's requirements for clinical trial lay summaries at Pharma 2023.
EUPATI offers the following resources for sponsors looking for information on lay summaries:
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
What This Study Means for Sponsors Still Struggling to Justify RBQM at Scale
2
ACT Brief: Hidden RBQM Value, Rare Disease Patient Partnership, and Safety Perception in IBD
3
From Participation to Understanding: Reframing Engagement in Clinical Trials
4
Beyond Compliance: NetraMark's Joseph Geraci, PhD, on Making AI-Driven Patient Subgroups Explainable
5




